CL2011000039A1 - Uso de un fosfopeptido que comprende la segunda serp-serp-serp-glu-glu que sirve para preparar una composicion farmaceutica util para aumentar el rendimiento lechero de ganado en lactancia luego de la paricion comparado con el rendimiento lechero antes de la paricion (divisional de la sol. 1028-2006). - Google Patents

Uso de un fosfopeptido que comprende la segunda serp-serp-serp-glu-glu que sirve para preparar una composicion farmaceutica util para aumentar el rendimiento lechero de ganado en lactancia luego de la paricion comparado con el rendimiento lechero antes de la paricion (divisional de la sol. 1028-2006).

Info

Publication number
CL2011000039A1
CL2011000039A1 CL2011000039A CL2011000039A CL2011000039A1 CL 2011000039 A1 CL2011000039 A1 CL 2011000039A1 CL 2011000039 A CL2011000039 A CL 2011000039A CL 2011000039 A CL2011000039 A CL 2011000039A CL 2011000039 A1 CL2011000039 A1 CL 2011000039A1
Authority
CL
Chile
Prior art keywords
serp
glu
milk yield
partitioning
pharmaceutical composition
Prior art date
Application number
CL2011000039A
Other languages
English (en)
Spanish (es)
Inventor
Jose Mario Iscovich
Javier Iscovich
Nissim Silanikove
Original Assignee
Mileutis Ltd Y State Of Israel Ministry Of Agriculture Agricultural Res Organization The Volcani Cen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd Y State Of Israel Ministry Of Agriculture Agricultural Res Organization The Volcani Cen filed Critical Mileutis Ltd Y State Of Israel Ministry Of Agriculture Agricultural Res Organization The Volcani Cen
Publication of CL2011000039A1 publication Critical patent/CL2011000039A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CL2011000039A 2005-05-02 2011-01-07 Uso de un fosfopeptido que comprende la segunda serp-serp-serp-glu-glu que sirve para preparar una composicion farmaceutica util para aumentar el rendimiento lechero de ganado en lactancia luego de la paricion comparado con el rendimiento lechero antes de la paricion (divisional de la sol. 1028-2006). CL2011000039A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67629205P 2005-05-02 2005-05-02
US68869705P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
CL2011000039A1 true CL2011000039A1 (es) 2011-06-10

Family

ID=37308387

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000039A CL2011000039A1 (es) 2005-05-02 2011-01-07 Uso de un fosfopeptido que comprende la segunda serp-serp-serp-glu-glu que sirve para preparar una composicion farmaceutica util para aumentar el rendimiento lechero de ganado en lactancia luego de la paricion comparado con el rendimiento lechero antes de la paricion (divisional de la sol. 1028-2006).

Country Status (18)

Country Link
US (2) US7968513B2 (enExample)
EP (1) EP1890720B1 (enExample)
JP (1) JP5247429B2 (enExample)
KR (2) KR20130122979A (enExample)
CN (1) CN106421749A (enExample)
AR (1) AR059462A1 (enExample)
AU (1) AU2006242842B2 (enExample)
BR (1) BRPI0611301A2 (enExample)
CA (1) CA2607155C (enExample)
CL (1) CL2011000039A1 (enExample)
EA (1) EA016039B1 (enExample)
ES (1) ES2400511T3 (enExample)
IN (1) IN2014DN10391A (enExample)
MX (1) MX2007013866A (enExample)
NZ (1) NZ563936A (enExample)
PL (1) PL1890720T3 (enExample)
UY (1) UY29515A1 (enExample)
WO (1) WO2006117784A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY29515A1 (es) * 2005-05-02 2007-11-30 Mileutis Ltd Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos
JP5507555B2 (ja) * 2008-06-30 2014-05-28 チョ−エー・ファーム・カンパニー・リミテッド 豚のαＳ１カゼイン遺伝子、そのプロモーター、及びその用途
US8133916B1 (en) 2009-03-10 2012-03-13 Amelgo, LLC Control of milk production and mammary involution
US20110017323A1 (en) * 2009-07-22 2011-01-27 Ewa Herbst Method and apparatus for inline testing
CA2797658C (en) * 2010-04-21 2021-06-08 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections
FR2971423B1 (fr) * 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
ES2759980T3 (es) * 2012-03-19 2020-05-12 Mileutis Ltd Péptidos para el manejo de la lactación
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins
NZ753824A (en) * 2016-11-09 2022-08-26 Charles Sturt Univ Livestock supplement and use thereof
AU2017376402B2 (en) * 2016-12-13 2021-10-28 Dsm Ip Assets B.V. PUFA salt formulations (I)
CN108017709B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
US20230106635A1 (en) * 2020-02-19 2023-04-06 Perfect Day, Inc. Hypoallergenic recombinant milk proteins and compositions comprising the same
EP4329790A1 (en) * 2021-04-28 2024-03-06 Mileutis Ltd. Compositions and methods for modulating mammary disorders and conditions
CN120379680A (zh) * 2022-11-17 2025-07-25 米勒尤迪斯公司 用于调节乳腺病症和病状的组合物和方法
CN121358342A (zh) * 2023-05-16 2026-01-16 米勒尤迪斯公司 提升的乳质
WO2026159713A1 (en) * 2025-01-23 2026-07-30 Mileutis Ltd. A method of increasing milk production

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
US5405756A (en) * 1982-03-30 1995-04-11 Meiji Seika Kaisha, Ltd. Transparent acid drink containing acid-soluble casein phosphopeptide
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
ES2149771T3 (es) * 1991-04-19 2000-11-16 Univ Melbourne Produccion de fosfopeptidos a partir de la caseina.
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AU775999B2 (en) 1999-08-24 2004-08-19 Meiji Seika Pharma Co., Ltd. Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same
US6391849B1 (en) * 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
JPWO2002072629A1 (ja) * 2001-03-09 2004-07-02 明治製菓株式会社 免疫増強剤
KR20070007128A (ko) 2004-03-01 2007-01-12 펩테라 파마슈티컬스 엘티디. 카제인 파생 펩타이드들과 그의 치료적 사용들
UY29515A1 (es) * 2005-05-02 2007-11-30 Mileutis Ltd Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos

Also Published As

Publication number Publication date
JP5247429B2 (ja) 2013-07-24
EA200702401A1 (ru) 2008-08-29
WO2006117784A2 (en) 2006-11-09
IN2014DN10391A (enExample) 2015-08-14
BRPI0611301A2 (pt) 2010-08-31
US7968513B2 (en) 2011-06-28
EA016039B1 (ru) 2012-01-30
JP2008540399A (ja) 2008-11-20
CA2607155C (en) 2016-09-13
NZ563936A (en) 2010-03-26
CA2607155A1 (en) 2006-11-09
EP1890720A2 (en) 2008-02-27
WO2006117784A3 (en) 2009-05-22
US20090069218A1 (en) 2009-03-12
US8338363B2 (en) 2012-12-25
ES2400511T3 (es) 2013-04-10
US20110212886A1 (en) 2011-09-01
KR20080012933A (ko) 2008-02-12
EP1890720B1 (en) 2013-01-09
KR101340676B1 (ko) 2013-12-18
CN106421749A (zh) 2017-02-22
AU2006242842A1 (en) 2006-11-09
PL1890720T3 (pl) 2013-06-28
EP1890720A4 (en) 2010-05-26
AR059462A1 (es) 2008-04-09
AU2006242842B2 (en) 2011-12-08
KR20130122979A (ko) 2013-11-11
UY29515A1 (es) 2007-11-30
MX2007013866A (es) 2008-04-07

Similar Documents

Publication Publication Date Title
Nongonierma et al. Unlocking the biological potential of proteins from edible insects through enzymatic hydrolysis: A review
AR078779A1 (es) Producto de la proteina de suero de leche y un metodo para su preparacion
CN101687022A8 (zh) Prame衍生的肽以及包括该肽的免疫原组合物
ATE391791T1 (de) Membran penetrierende peptide und deren anwendungen
BR112012006579A2 (pt) agonistas de npr-b.
AR064254A1 (es) Maiz extraido con solvente
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
EA201390998A1 (ru) Препарат фторуглеродсвязанных пептидов
EA200702401A1 (ru) Фармацевтические композиции, включающие выделенные из казеина пептиды, и способы их применения
CU24746B1 (es) Apirasas humanas, solubilizadas y modificadas útiles para prevenir y tratar el daño tisular
PT1079849E (pt) Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica
CL2020002843A1 (es) Uso de un bolo oral en el secado de ganado lechero
MA32770B1 (fr) Anticorps anti-peptides igf-1/e humain modifie
BR0309491A (pt) Composição de vacina, composição imunogênica, utilização de uma proteìna e7 e anticorpos neutralizantes
ES2507094T3 (es) Proteína específica del timo
TW200505943A (en) Polypeptide
RU2015103059A (ru) Суперагонисты гликопротеинового гормона длительного действия
CN103554228B (zh) 一种GnRH去势疫苗及并列体
WO2002040529A3 (en) Diastereomeric peptides and pharmaceutical compositions comprising them
Bhattacharya et al. Biotechnology input in fish breeding
JPH03503403A (ja) 生物学的に活性な分子
TW201520231A (zh) 耐高鹽及抗蛋白之抗菌胜肽及其製造方法
AR087727A1 (es) Analogos del factor de liberacion de la hormona de crecimiento (grf) y sus usos
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
AR098732A1 (es) Un proceso para la preparación de una composición de proteínas pegiladas